Ihor Seredyuk

Ihor Seredyuk

Auto-generated profile, based on publicly available information

Ihor Seredyuk

Ivano-Frankivsk National Medical University

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2026 in DENTISTRY. MEDICINE. REHABILITATION
Verified
Journal Article
Open access
PDF file
NMNataliia Makhlynets
Nataliia Makhlynets
MKMyroslava Kokoshko
Myroslava Kokoshko
NPNataliia Pavelko
Nataliia Pavelko
ISIhor Seredyuk
Ihor Seredyuk
NMNadiia Melnyk
Nadiia Melnyk
НМНадія Мельник
Надія Мельник
Relevance. Improving the effectiveness of the diagnosis and comprehensive treatment of patients with dentoalveolar anomalies associated with disturbances in the oral vestibule architectonics remains a significant issue in modern dentistry. This is due to the fact that anatomical structures, such as labial frenula, buccal bands, and ankyloglossia, serve as important etiological factors in the development of dentoalveolar anomalies, may contribute to relapse after orthodontic treatment, and can lead to gingival recession. This issue also has legal significance, as the effectiveness of treatment depends on appropriate regulatory support and the actual availability of specialized dental care within the healthcare system. The limited incorporation of modern evidence-based approaches into clinical standards, along with unequal patient access to comprehensive treatment, necessitates the improvement of legal and organizational mechanisms to ensure the quality of medical care. The objective is to evaluate the effectiveness of the comprehensive treatment of patients with dentoalveolar anomalies associated with altered oral vestibule architectonics using surgical correction and different postoperative therapeutic approaches. Furthermore, it aims to substantiate the need to improve the regulatory and legal framework and to integrate contemporary evidence-based approaches into the system of public health policy in Ukraine. Materials and Methods. The study involved 30 patients aged 12–15 years with dentoalveolar anomalies and disturbances in oral vestibule architectonics. All patients underwent surgical correction of the oral vestibule using the conventional method, with wound healing by secondary intention. The patients were divided into two groups: Group I received Chlorhexidine-Denta during the postoperative period; Group II received a combination of Chlorhexidine-Denta and a hyaluronic acid–based gel (Gengigel). Clinical, cytomorphometric, and rheographic examinations were performed to assess the condition of the oral vestibule tissues. Results. Patients demonstrated pronounced alterations in oral vestibule architectonics: the height of labial frenulum attachment was less than 5 mm, and connective tissue bands in the canine and premolar regions were present in 96.7% (29/30) of cases. Clinical and laboratory findings indicated reduced blood supply to the vestibular tissues. After treatment, statistically significant differences were observed between the two groups (p < 0.05). Patients in Group II showed superior outcomes, including the formation of normotrophic scars, the absence of relapse and gingival recession in the canine and premolar regions, as well as the normalization of clinical and laboratory parameters. Conclusions. A comprehensive approach to the treatment of oral vestibule architectonic disturbances, including surgical correction and the use of hyaluronic acid–based agents in the postoperative period, ensures improved clinical outcomes, promotes optimal tissue healing, and significantly reduces the risk of complications and relapse.

4 April 2026 in Art of Medicine
Verified
Journal Article
Open access
PDF file
НСН. М. Середюк
Н. М. Середюк
ІВІ. П. Вакалюк
І. П. Вакалюк
ВСВ. Н. Середюк
В. Н. Середюк
ТНТ. В. Налужна
Т. В. Налужна
ХЛХ. В. Левандовька
Х. В. Левандовька
ІCІ. Н. Cередюк
І. Н. Cередюк
The problem of treating stable angina, as the most common clinical form of coronary artery disease and chronic coronary syndrome (CHS), lies in the difficulty of selecting a complex of antianginal drugs due to co-, polymorbidity, side effects, and the uncertainty of the root cause of the disease in a particular patient. All of the above makes it difficult to prescribe effective up stream therapy. Meanwhile, many of the above problems could be avoided by adding modern nutraceutical complexes recommended by relevant studies to the classic personalized therapy regimen. Among the most attractive, in our opinion, is the complex recently introduced to the pharmaceutical market of Ukraine, which includes: DHA 400mg + Policonasol 20mg) – “Cardionevrin Forte” [10]. The aim of the study was to analyze the effect of the new nutraceutical complex "Cardioneurin Forte" on cardiodynamics and lipid metabolism indicators and to develop recommendations for its inclusion in the treatment of CHD/CHD-stable angina with arterial hypertension and dyslipidemia. In this study, the therapeutic efficacy of the nutraceutical complex "Cardioneurin Forte" was compared with the control group by the dynamics of lipid spectrum indicators referring to data, obtained in the study of the nutraceutical complex "Cardioneurin" [17]. A total of 90 patients participated in the two studies. In the previous study (n = 60), the therapeutic efficacy and safety of the nutraceutical complex with a policosanol content of 10 mg was evaluated, while in the last study (n = 30) the efficacy of the new nutraceutical complex was studied, in which the dose of policosanol was doubled - to 20 mg. The nutraceutical complex "Cardioneurin Forte" enhances antianginal, antihypertensive properties and hemodynamic characteristics and effectively improves the dynamics of lipid metabolism in patients with coronary artery disease/chronic ischemic heart disease - stable angina. Conclusions. Strengthening of the antianginal and antihypertensive properties of standard drug pharmacotherapy with adding of the nutraceutical complex "Cardioneurin Forte" is characterized by increased physical activity, decreased shortness of breath, palpitations in comparison with the less pronounced dynamics of these clinical signs in the control group in the same direction, as well as more pronounced in the main group (standard treatment in combination with the studied nutraceutical complex) step-by-step antihypertensive therapy. Improvement of biomechanics of systolic and diastolic functions of the left ventricle according to Echocardiography and Speckle Tracking EchoCG data is more pronounced when adding the nutraceutical complex "Cardioneurin Forte" to the standard therapy of CHD/CHD-stable angina pectoris FC III. The lipid-lowering effect of the studied nutraceutical complex is not a replacement for pharmaceutical hypolipidemic drugs (statin therapy/bempedoic acid, ezetimibe, PCSK-9 inhibitors, inclisiran), but a significant addition to the standard treatment of CHD/CHD-stable angina pectoris with arterial hypertension and dyslipidemia. The positive effect of the recommended combination therapy is due to an increase in HDL-C levels, a decrease in non-HDL-C, LDL-C, and triacylglycerols in the presence of hypercholesterolemia and hypertriacylglycerolemia.